Treatment of cognitive disorders with (R)-7-chloro-N-(quinuclidin-3-yl) benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof

Details for Australian Patent Application No. 2009316557 (hide)

Owner EnVivo Pharmaceuticals, Inc.

Inventors Koenig, Gerhard; Chesworth, Richard; Shapiro, Gideon

Agent Spruson & Ferguson

Pub. Number AU-A-2009316557

PCT Pub. Number WO2010/059844

Priority 61/116,106 19.11.08 US

Filing date 19 November 2009

Wipo publication date 27 May 2010

International Classifications

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

Event Publications

16 June 2011 PCT application entered the National Phase

  PCT publication WO2010/059844 Priority application(s): WO2010/059844

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009316562-Multi-layered support system and method thereof

2009316547-System and method for molding soft fluid-filled implant shells